Teva Pharmaceuticals Enters Partnership with Procter & Gamble

Teva Pharmaceuticals TEVA shares are rising after the company announced it has signed an agreement with Proctor & Gamble PG to create a partnership that will combine both companies' over-the-counter medicine divisions. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on TEVA. TEVA opened Thursday morning at $50.13. In morning trading, the stock hit a low of $49.86 and a high of $50.59. As of 12:20, TEVA was trading at $50.58 up $1.46 (3.0%). The chart for TEVA looks bullish and S&P gives TEVA a positive 4 stars (out of 5) buy ranking. Continue reading the article.